News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
305,298 Results
Type
Article (8381)
Company Profile (7)
Press Release (296910)
Section
Business (97986)
Career Advice (57)
Deals (21588)
Drug Delivery (25)
Drug Development (37130)
Employer Resources (11)
FDA (5685)
Job Trends (6384)
News (159851)
Policy (11166)
Tag
Academia (254)
Alliances (14543)
Alzheimer's disease (587)
Approvals (5719)
Artificial intelligence (63)
Bankruptcy (147)
Best Places to Work (6026)
Breast cancer (114)
Cancer (943)
Cardiovascular disease (67)
Cell therapy (193)
Clinical research (31319)
Collaboration (297)
Compensation (328)
COVID-19 (606)
C-suite (96)
Cystic fibrosis (55)
Data (1140)
Diabetes (112)
Diagnostics (3101)
Earnings (58546)
Events (71452)
Executive appointments (341)
FDA (6184)
Funding (448)
Gene therapy (125)
GLP-1 (268)
Government (634)
Healthcare (8477)
Infectious disease (649)
Inflammatory bowel disease (62)
IPO (13205)
Job creations (749)
Layoffs (95)
Legal (2584)
Lung cancer (149)
Lymphoma (61)
Manufacturing (94)
Medical device (7222)
Medtech (7223)
Mergers & acquisitions (8820)
Metabolic disorders (303)
Neuroscience (818)
NextGen: Class of 2025 (2345)
Non-profit (292)
Northern California (1642)
Obesity (157)
Opinion (75)
Patents (109)
People (22307)
Phase I (9624)
Phase II (14066)
Phase III (10604)
Pipeline (611)
Postmarket research (725)
Preclinical (3536)
Radiopharmaceuticals (173)
Rare diseases (188)
Real estate (1136)
Regulatory (8666)
Research institute (309)
Series A (99)
Series B (65)
Southern California (1353)
Startups (2131)
United States (13305)
Vaccines (178)
Weight loss (97)
Date
Today (54)
Last 7 days (616)
Last 30 days (1905)
Last 365 days (22962)
2025 (3668)
2024 (23547)
2023 (26881)
2022 (29744)
2021 (32483)
2020 (28189)
2019 (18744)
2018 (13737)
2017 (15399)
2016 (12305)
2015 (16877)
2014 (11158)
2013 (7454)
2012 (8169)
2011 (8725)
2010 (7732)
Location
Africa (150)
Arizona (60)
Asia (15949)
Australia (2967)
California (3600)
Canada (1169)
China (151)
Colorado (152)
Connecticut (179)
Delaware (58)
Europe (38797)
Florida (484)
Georgia (120)
Illinois (182)
Indiana (222)
Japan (73)
Kansas (61)
Maryland (427)
Massachusetts (2937)
Michigan (124)
Minnesota (236)
New Jersey (970)
New York (1074)
North Carolina (525)
Northern California (1642)
Ohio (68)
Pennsylvania (773)
South America (328)
Southern California (1353)
Texas (530)
Utah (102)
Washington State (370)
305,298 Results for "gryphon investors".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Gryphon Bio, Inc. Pioneers Novel Blood Biomarker Panel to Monitor Treatment Journey for Patients with Traumatic Brain Injury and Alzheimer’s
January 14, 2025
·
2 min read
Deals
Gryphon Investors Acquires Vetnique Labs
Gryphon Investors (“Gryphon”), a leading middle-market private equity firm, today announced that it has acquired Vetnique Labs (“Vetnique” or the “Company”).
April 20, 2023
·
4 min read
Biotech Bay
Gryphon Investors To Sell CORA Physical Therapy
- Gryphon Investors (“Gryphon”), a leading middle-market private equity firm, announced today that it has signed a definitive agreement to sell its portfolio company CORA Health Holdings Corp. (“CORA,” “CORA Physical Therapy,” or “the Company”) to an affiliate of H.I.G. Capital. Gryphon originally invested in the Company in July 2016 .
May 25, 2021
·
2 min read
Press Releases
Dynavax to Participate in Upcoming Investor Conferences
February 26, 2025
·
1 min read
Press Releases
Avidity Biosciences to Participate in Upcoming Investor Conferences
February 25, 2025
·
2 min read
Press Releases
Alterome Therapeutics to Participate in Upcoming Investor Conferences
February 25, 2025
·
1 min read
Press Releases
TransMedics to Present at Upcoming March Investor Conferences
February 18, 2025
·
1 min read
Press Releases
Anaptys Announces Participation in March 2025 Investor Conferences
February 28, 2025
·
1 min read
Press Releases
Revolution Medicines to Participate in March 2025 Investor Conferences
February 24, 2025
·
1 min read
Press Releases
Zevra to Participate at Upcoming March 2025 Investor Conferences
February 25, 2025
·
2 min read
1 of 30,530
Next